| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,750 |
14,020 |
$452K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
2,437 |
1,900 |
$88K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
1,933 |
871 |
$61K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,992 |
483 |
$53K |
| J0897 |
Injection, denosumab, 1 mg |
248 |
210 |
$35K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
218 |
192 |
$7K |
| 99406 |
|
795 |
701 |
$6K |
| 76770 |
|
197 |
169 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
237 |
185 |
$5K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
290 |
130 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,635 |
1,901 |
$4K |
| 81002 |
|
1,375 |
1,161 |
$1K |
| 99223 |
Prolong inpt eval add15 m |
71 |
50 |
$1K |
| 85018 |
|
2,689 |
2,077 |
$141.97 |
| 99441 |
|
249 |
198 |
$91.69 |